Emergent Devices

Emergent Devices Inc., a subsidiary of Emergent BioSolutions, is a specialty pharmaceutical company focused on addressing public health crises, particularly the opioid epidemic. The company is best known for Narcan (naloxone hydrochloride) Nasal Spray, a life-saving medication used to reverse the effects of an opioid overdose. Emergent Devices became a key part of the Emergent BioSolutions portfolio following the acquisition of Adapt Pharma in 2018. The company manages the commercialization, distribution, and regulatory strategy for Narcan, which is available both by prescription and over-the-counter. Through partnerships with government agencies and community organizations, Emergent Devices works to ensure broad access to overdose reversal agents. Its operations are centered on providing rapid-response medical solutions for emergency situations.